Dr. Chris Smyth, president of ICON Biotech, discusses emerging trends in the biotech space.
Chris Smyth
Advertisement
Articles by Chris Smyth
Advertisement
Latest Updated Articles
Capitalizing On Collaboration and Confidence: Survey Insights and Expectations For Biotech in 2024Published: February 2nd 2024 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
